Insider · CIK 0001410514

Kelly Thomas Patrick

Reports to the SEC for 3 companies · BURNABY

sec.gov

Transactions

Companies

Filings

CIK

0001410514

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	XENEXenon Pharmaceuticals Inc.P Purchase	Chief Financial Officer	PPurchase	+15K sh	$37.32	+$560K	15,000
2025-10-15	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Chief Financial Officer	AAward	+225K sh	—	—	225,000
2025-10-15	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Chief Financial Officer	AAward	+30K sh	—	—	30,000
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−82.3K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+34.2K sh	—	—	114,507
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−65.9K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−82K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−69.1K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−72K sh	—	—	42,478
2024-06-11	Deciphera Pharmaceuticals, Inc.U Disposition from Tender	Chief Financial Officer	UDisposition from Tender	−42.5K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−5,650 sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−103K sh	—	—	0
2024-06-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−85.5K sh	—	—	0
2024-02-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−3,010 sh	$15.62	−$47K	80,350
2024-02-15	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+69.1K sh	—	—	69,100
2024-02-15	Deciphera Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+17.3K sh	—	—	83,360
2024-01-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−2,435 sh	$14.47	−$35.2K	66,085
2023-12-13	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−2,792 sh	$15.37	−$42.9K	68,520
2023-12-12	Deciphera Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+8,244 sh	—	—	71,312
2023-10-30	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−2,316 sh	$12.02	−$27.8K	63,068
2023-10-28	Deciphera Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+8,244 sh	—	—	65,384
2023-06-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−1,655 sh	$14.40	−$23.8K	57,140
2023-02-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−1,370 sh	$15.10	−$20.7K	58,795
2023-02-15	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+65.9K sh	—	—	65,900
2023-02-15	Deciphera Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+16.5K sh	—	—	60,165
2023-01-17	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−2,403 sh	$21.24	−$51K	43,677
2022-06-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−1,768 sh	$10.75	−$19K	46,080
2022-02-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−1,368 sh	$9.05	−$12.4K	47,848
2022-01-18	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+82K sh	—	—	82,000
2022-01-18	Deciphera Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+20.5K sh	—	—	49,216
2021-12-15	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+82.3K sh	—	—	82,265
2021-12-15	Deciphera Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+11.1K sh	—	—	28,716
2021-02-16	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+49.9K sh	—	—	49,900
2021-02-16	Deciphera Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+11.1K sh	—	—	17,616
2021-02-16	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−524 sh	$48.87	−$25.6K	6,516
2020-09-14	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,000 sh	—	—	47,008
2020-09-14	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−3,000 sh	$50.01	−$150K	7,040
2020-09-14	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,000 sh	$1.89	+$5,670	10,040
2020-09-10	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,000 sh	—	—	50,008
2020-09-10	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−3,000 sh	$47.71	−$143K	7,040
2020-09-10	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,000 sh	$1.89	+$5,670	10,040
2020-09-08	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−3,700 sh	$45.23	−$167K	8,540
2020-09-08	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−800 sh	$44.69	−$35.8K	12,240
2020-09-08	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+6,000 sh	$1.89	+$11.3K	13,040
2020-09-08	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−1,500 sh	$46.55	−$69.8K	7,040
2020-09-08	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−6,000 sh	—	—	53,008
2020-05-11	Deciphera Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12K sh	—	—	59,008
2020-05-11	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−2,605 sh	$55.56	−$145K	7,040
2020-05-11	Deciphera Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12K sh	$1.89	+$22.7K	19,040
2020-05-11	Deciphera Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−9,395 sh	$55.08	−$518K	9,645

Recent filings

Accepted (ET)
Oct 14
Kelly Thomas Patrick0001193125-26-410001
SEC(opens sec.gov)
Oct 174
Kelly Thomas Patrick0001193125-25-242700
SEC(opens sec.gov)
Jun 114
Kelly Thomas Patrick0000950170-24-072221
SEC(opens sec.gov)
Feb 204
Kelly Thomas Patrick0000950170-24-017091
SEC(opens sec.gov)
Jan 184
Kelly Thomas Patrick0000950170-24-005389
SEC(opens sec.gov)
Dec 144
Kelly Thomas Patrick0000950170-23-070384
SEC(opens sec.gov)
Oct 314
Kelly Thomas Patrick0001209191-23-053936
SEC(opens sec.gov)

Companies

Address

3650 GILMORE WAY

BURNABY, V5G 4W8